로딩 중…
지수 로딩 중…
Septerna, Inc.
SEPN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$34.98+1.54%
2026-08-03
Financials
Valuation Metrics
Septerna, Inc.'s Market Cap is $1.58B. At end of 2025 it was $1.23B. Ranked #2211 of 3,111 in US market (top 71%), #872 of 1,445 on NASDAQ (top 60%), #160 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 59%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.58B | US#2,211/3,111 Sec#160/269 |
| Revenue | $72M | US#2,839/3,111 Sec#141/269 |
| Net Income | $-36M | US—/3,111 Sec—/269 |
| Total Assets | $570M | US#2,706/3,111 Sec#142/269 |
| Net Assets | $378M | US#2,439/3,111 Sec#144/269 |
| Value | ||
| P/B | 4.17x | US#2,016/3,111 Sec#123/269 |
| P/S | 21.82x | US#2,828/3,111 Sec#148/269 |
| FCF Yield | 6.78% | US#909/3,111 Sec#32/269 |
| Profitability | ||
| ROE | -9.52% | US#2,404/3,111 Sec#89/269 |
| ROA | -6.33% | US#2,575/3,111 Sec#97/269 |
| Op. Margin | -77.07% | US#2,808/3,111 Sec#119/269 |
| Revenue Growth | 12010.96% | US#8/3,111 Sec#2/269 |
| Financial Health | ||
| Debt Ratio | 50.53% | US#583/3,111 Sec#142/269 |
| Total Debt | $23M | US#2,705/3,111 Sec#177/269 |
| FCF | $107M | US#1,645/3,111 Sec#61/269 |
| Cash | $72M | US#2,410/3,111 Sec#203/269 |
| Current Ratio | 4.71x | US#508/3,111 Sec#154/269 |
| Performance | ||
| 1Y Return | 186.49% | US#116/3,111 Sec#41/269 |
| 1M Return | 2.88% | US#1,602/3,111 Sec#105/269 |
| From 52W High | -8.04% | US#932/3,111 Sec#53/269 |
| 1Y MDD | -25.18% | US#1,045/3,111 Sec#58/269 |
| Trading | ||
| Volume | 198,936 shares | US#2,525/3,111 Sec#243/269 |
| Trading Value | $7M | US#2,397/3,111 Sec#194/269 |
| Per Share | ||
| EPS | $-1.10 | US—/3,111 Sec—/269 |
| BPS | $8.63 | US#1,886/3,111 Sec#76/269 |